Development and characterization of a canine oral mucosa equivalent in a serum-free environment by Song, Junhui et al.
Development and characterization of a canine oral mucosa
equivalent in a serum-free environment
Junhui Song,1 Kenji Izumi,1,2 Thomas Lanigan,3 Stephen E. Feinberg1
1Department of Oral and Maxillofacial Surgery, University of Michigan Medical Center, 1500 East Medical Center
Drive, Ann Arbor, Michigan 48109-0018
2Department of Oral and Maxillofacial Surgery, Niigata University, Niigata, Japan
3Center of Gene Therapy, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor,
Michigan 48109-0018
Received 2 April 2004; revised 3 June 2004; accepted 15 June 2004
Published online 18 August 2004 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/jbm.a.30144
Abstract: The objectives of this study were to develop a
serum-free system for culturing canine oral keratinocytes,
the construction and characterization of a canine ex vivo
produced oral mucosa equivalent (EVPOME), and transduc-
tion green fluorescent protein (GFP) into keratinocytes as a
post-grafting tracking marker. Dissociated canine buccal
mucosa keratinocytes were cultured in a chemically defined
serum-free medium, Epilife™. First-passage keratinocytes
were transfected with the GFP gene using a lentiviral vector,
sorted by flow cytometer and seeded onto a dermal equiv-
alent, AlloDerm to form EVPOMEs. The EVPOME was
characterized by histology and immunohistochemistry, for
p63, Ki-67, and involucrin. Laser confocal microscopy was
used to locate GFP-transfected keratinocytes within the EV-
POME. Cultured canine oral keratinocytes grew rapidly
over the first three passages and then the proliferative rate
decreased. The canine EVPOME formed a well-stratified
epithelial layer. The majority of p63 and Ki-67 immunopo-
sitive cells were located in the basal layer whereas cytoplas-
mic involucrin expression was seen in the suprabasal layers,
similar to native canine buccal mucosa. Under laser confocal
microscopy, significant green fluorescence was observed
throughout the EVPOME. In conclusion, canine EVPOMEs
were successfully fabricated in a defined serum-free system
with similar characteristics to native buccal mucosa. GFP-
transfected canine oral keratinocytes could be identified
within the EVPOME. © 2004 Wiley Periodicals, Inc. J Biomed
Mater Res 71A: 143–153, 2004
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INTRODUCTION
Oral and maxillofacial surgeons are frequently con-
fronted with a shortage of oral mucosa for reconstruc-
tion of the oral cavity. Routine use of split-thickness
skin grafts has disadvantages, such as presence of
adnexal structures and a different pattern of keratini-
zation. Cultured autologous oral keratinocyte sheets
and oral mucosa equivalents constructed on collagen
dermal equivalents are easily degraded and not suited
for intraoral clinical applications.1,2 We have previ-
ously developed a human ex vivo produced oral mu-
cosa equivalent (EVPOME) by culturing human oral
keratinocytes and seeding them onto a cadaveric der-
mal equivalent, AlloDerm (Lifecell Corp., Branch-
burg, NJ), in a serum-free culture system without us-
ing an irradiated 3T3 xenogeneic feeder cell layer. The
seeded human oral keratinocytes formed a stratified
epithelial layer on the dermal component of the EV-
POME when it was raised to an air–liquid interface,
developing into an epithelial layer that was similar to
the original oral mucosa used to fabricate it.3 Subcu-
taneous grafting of human EVPOME into SCID mice
showed the importance of the presence of a mature
epithelia in the growth and formation of microvessels
within the dermis of the EVPOME as compared with
the dermal equivalent, AlloDerm, lacking an epithe-
lial layer.4 Human EVPOMEs used clinically in pa-
tients to reconstruct oral defects showed the persis-
tence of epithelial cells on the grafts at 7 days after
transplantation by cytological smear. In addition,
postoperatively, the epithelial layer of the grafted EV-
POME appeared better organized, and the inflamma-
tory response in underlying the dermal equivalent
was less pronounced than the AlloDerm grafts lack-
Correspondence to: S. E. Feinberg; e-mail: sefein@umich.edu
Contract grant sponsor: Kato Memorial Bioscience Foun-
dation (to KI)
Contract grant sponsor: US PHS; contract grant number:
NIDCR/NIH R01 DE 13417 (to SEF)
© 2004 Wiley Periodicals, Inc.
ing an epithelial layer, demonstrating the importance
of the barrier effect of the grafted epithelial layer.2 It is
important to assess the longevity and ultimate fate of
the grafted epithelium on the EVPOMEs. To be able to
do this appropriately will necessitate labeling trans-
planted oral keratinocytes to be able to differentiate
them from ungrafted cells. These are studies that can-
not ethically be performed on humans, thus the need
for a comparable animal model, such as the dog, that
would allow these and other in vivo studies to be
performed.
Our research team has successfully fabricated a hu-
man tissue-engineered oral mucosa in a defined me-
dium free of serum and a xenogeneic feeder layer that
will be used in an upcoming clinical trial.5 The dog
presents an excellent animal model for performing
identical intraoral studies as are planned in our clini-
cal trial because it has similar soft tissues and is large
enough to do surgical procedures that are performed
in humans.6–8 To be able to extrapolate the studies
performed in dogs to our human EVPOME, the canine
EVPOME needs to be fabricated in a manner that is
consistent with the process of fabricating human
EVOPME, following Food and Drug Administration
(FDA) guidelines for cells grown in vitro that are
grafted back in humans.5 To date, several investiga-
tions that have attempted to culture canine oral kera-
tinocytes used irradiated 3T3 xenogeneic fibroblast as
a feeder layer, and/or a high concentration of serum
in the medium.9–13 The use of a 3T3 feeder layer
and/or serum places the cultured oral keratinocytes at
a risk of cross-contamination with viral and/or other
material, such as prions and conflicts with FDA guide-
lines. Crameri et al.9 indicated that several commercial
serum-free culture media, such as KGM™ (Cambrex,
Santa Rosa, CA) and KSFM™ (Gibco, Grand Island,
NY), are only effective on normal human oral keratin-
ocytes, and neoplastic canine oral keratinocytes but
not on normal canine oral keratinocytes. Ophof et al.11
have compared various materials to construct a canine
oral mucosa equivalent, including AlloDerm, and
several variations made from type 1 collagen. The
seeded canine oral keratinocytes only formed a con-
tinuous epithelial layer, similar to native mucosa on
the AlloDerm dermal equivalent. It demonstrated
that a synthetic dermal substitute, such as collagen,
could only be effective in forming a basement mem-
brane and epithelial layer when fibroblasts were
present within the dermal equivalent, otherwise the
seeded keratinocytes would migrate into the underly-
ing porous collagen and form cell clusters or cysts.
It was evident that we needed to develop a technique
to fabricate a canine EVPOME, similar to human
EVPOME, in a defined serum-free system devoid of a
feeder layer. The results from the canine in vivo inves-
tigations could then be extrapolated to humans and
used for eventual FDA approval for human EVPOME.
Thus, the objectives of this study were to:
1. develop a serum-free system without a feeder
layer for predictable culturing of canine oral ker-
atinocytes,
2. construct a full-thickness oral mucosa equivalent,
in vitro, in a chemically defined system,
3. characterize the developing epithelium on the
canine EVPOME, and
4. transduce a reporter gene, green fluorescent pro-
tein (GFP), into canine oral keratinocytes, with a
lentivirus vector, to serve as a marker for grafted
cells.
METHODS
Cell isolation and culture
The oral cavity of five euthanized mongrel dogs was
prepped with Betadine (Purdue Frederick, Stamford, CT),
and samples of buccal oral mucosa tissue were obtained
within 30 min after death. The excised tissues were washed
twice in Dulbecco’s phosphate-buffered saline (PBS) (BD
Whittaker, Walkersville, MD) supplemented with 125
g/mL Gentamycin and 1 g/mL Fungizone (Gibco), and
kept in the second washing for 30 min to remove any resid-
ual bacteria. After the subcutaneous tissue was trimmed off,
samples were cut into 2- to 3-mm-wide strips, digested in
0.1% trypsin (Sigma, St. Louis, MO) at room temperature
overnight (16–18 h). The same concentration of trypsin in-
hibitor (Sigma) was then used to neutralize the trypsin. The
epidermal side of the mucosa was gently scraped with a
scalpel to detach the keratinocytes. The resultant cell sus-
pension was filtered through a 400-micron mesh, centri-
fuged at 1000 rpm for 5 min, resuspended in Epilife™ ker-
atinocyte serum-free medium (Cascade Biologics, Portland,
OR) supplemented with 0.06 mM calcium, 25 g/mL Gen-
tamycin, and 0.375 g/mL Fungizone, and then seeded into
flasks at an initial density of 2  105 cells/cm2. Cells were
incubated at 37°C, 5% CO2 in humidified air; medium was
changed every other day. Once the keratinocyte cultures
attained 70–80% confluence, they were split and passaged
by washing with PBS, digested with 0.025% trypsin/ethyl-
enediaminetetraacetic acid (Cascade Biologics), neutralized
by defined 0.0125% trypsin inhibitor (Cascade Biologics),
centrifuged, and resuspended at a seeding density of 2  104
cells/cm2. Keratinocytes were then placed into serial culture
and carried until their proliferative ability was exhausted.
The seeding cell density of both the canine oral keratinocyte
primary culture and subcultures was similar to the cell
density used in our human keratinocyte cultures.3
Growth curve
To create a growth curve, the primary harvested keratin-
ocytes were seeded into a 24-well plate (Corning Inc., Corn-
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ing, NY) at an initial density of 2  105 cells/well. To
monitor the proliferation rate of cells, two wells were
trypsinized and counted every day up to 12 days after
seeding. Cell counts of each well were duplicated; mean
value was taken as the result. Growth curves were plotted as
cell number on a log scale, against time on a linear scale.
Data were presented as mean  SD. The lag time, popula-
tion doubling time, and plateau density of primary cells
were then determined as described elsewhere.14 Briefly, the
cumulative total cell number of cells was determined at each
passage based on the assumption that all cells from the
previous passage had been replated.3 The population dou-
bling time of passage one and passage two cells was calcu-
lated from the formula PD  [log (N/N0)]
1, where N  cell
number at harvest, N0  cell number inoculated, PDT 
I/PD, and I  interval (days) between the passages.15
Forward scatter count by flow cytometry
To further evaluate cell size and sort for labeled canine
keratinocytes grown in the Epilife™ serum-free culture sys-
tem, cells from each passage were trypsinized, pelleted, and
fixed in ice cold 90% methanol to a final density of 1 
106/mL, then stored at 20°C until use for flow cytometric
analysis. Cells were spun down and resuspended in an
equal amount of PBS before flow cytometry. Relative cell
size was determined by measuring forward and orthogonal
light scatter in a Coulter Flow Cytometer (Beckman Coulter
ESP, USA).
GFP gene transduction and flow cytometry
Dog oral keratinocytes from passage one or two were
seeded into a six-well plate. On the second day, 1.25 mL of
10 concentration of FIV34TF10/huGFP lentivirus resus-
pended in Epilife™ media (Vector Core; University of Mich-
igan, Ann Arbor, MI) was mixed with 8 g/mL polybrene
and added to the cells. The plate was then spin inoculated
for 90 min at 2500 rpm (Eppendorf Centrifuge 5810) and
then incubated at 32°C/5% CO2. After 22 h, the medium was
changed, and then subsequently changed every 48 h. One
week later, keratinocytes were harvested and resuspended
in PBS at 1  106/mL with propidium iodide 400 L/mL
(Sigma, St. Louis, MO), then sorted by flow cytometry
(FACS Vantage SE; Becton Dickinson, San Jose, CA) accord-
ing to GFP expression. The positive cells were harvested in
culture medium and seeded onto the dermal equivalent,
AlloDerm. As a negative control, we seeded nontrans-
duced cells from the same dog oral keratinocyte population.
Fabrication of canine EVPOME
Circular pieces of AlloDerm, 1.0 cm in diameter, were
rehydrated and coated with 5 g/cm2 type IV collagen
(Fluka, Buchs, Swizerland) as described previously.3 Kera-
tinocytes from passage one or two, which is the passage
number that is planned to be used in our human clinical
trial, were resuspended in high calcium (1.2 mM Ca)
Epilife™ medium and seeded onto the AlloDerm at the
density of 2.5  105 cells/cm2. Medium was changed every
day. On day 4, the AlloDerm/oral keratinocyte composites
were transferred to an air–liquid interface. Medium was
changed every other day. To assess the histological character
of the canine EVPOME, EVPOMEs were fixed with 10%
formalin at day 4, 11, and 18, after initial seeding of oral
keratinocytes, processed for routine histology, and 5-m-
thick sections were stained with hematoxylin and eosin. For
GFP-transfected EVPOME, frozen sections of 7-m thick-
ness were examined by a laser confocal microscope (MCR-
600; Bio-Rad, UK) using a wavelength of 488 nm.
Immunohistochemistry
Immnohistochemistry analysis was performed on na-
tive canine oral mucosa tissue on day 4, 11, and 18 EV-
POMEs to detect a stem cell marker, p63 (clone 4A4;
Pharmingen, San Diego, CA), a cell proliferation marker,
Ki-67 (clone Ki-67; Beckman Coulter, Fullerton, CA), and
a cell differentiation marker, involucrin (ab68; Abcam,
Cambridge, UK). For staining of p63 and Ki-67, samples
were fixed with 10% formalin, embedded in paraffin, and
cut at 5 m. After deparaffinizing, quenching of endoper-
oxidase activity was performed by 30-min incubation in
0.3% H2O2 with methanol. Antigen retrieval technique
was used for immunohistochemistry of p63 and Ki-67 by
microwave heating for 20 min in citrate buffer, pH 6.0.
Sections were incubated with mouse monoclonal anti-
human antibody to p63 (1:150), Ki-67 (1:80) overnight at
4°C. For involucrin, a 7-m frozen section was used and
incubated with mouse monoclonal anti-human involucrin
antibody (1:250) for 2 h at room temperature. Antibody
binding was performed with an anti-mouse immuno-
globulin G biotinylated antibody and avidin biotin com-
plex solution according to the protocol recommended
by the manufacturer and visualized by DAB (33-
diaminobenzidine) technique (Vector Laboratories, Bur-
lingame, CA). Sections were counterstained with hema-
toxylin. The cell counting method of immunopositive cells
was the same as previously stated.3
RESULTS
Cell isolation and culture
Phase-contrast microscopy
Under phase-contrast microscopy, cultured pri-
mary keratinocytes attached to the bottom of the
flasks and had a spindly cell shape and ruffled
membrane. It appeared that numerous keratinocytes
migrated by extending long “foot-like” appendages
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(pseudopodia). On confluence, the interface between
the keratinocytes became narrower with cells gradually
assuming a polygonal shape with a pavement-like ap-
pearance. In our culture system, canine oral keratino-
cytes could be passaged for, at the most, seven genera-
tions. In primary culture, the majority of the cells had a
small polygonal shape with several larger irregular ker-
atinocytes scattered among them. With each passage, the
proportion of larger cells increased. From passage two
on, the cells appeared as large “differentiated” keratin-
ocytes containing numerous granules within their cyto-
plasm (Fig. 1).
Figure 1. Phase-contrast micrographs of dog oral keratinocytes from generation passage P0 to P7 (original magnification,
100). Arrows in passage two cells (P2) indicate larger keratinocytes containing intracytoplasmic granules. [Color figure can
be viewed in the online issue, which is available at www.interscience.wiley.com.]
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Flow cytometry analysis
The change of cell size on passage was confirmed by
flow cytometry analysis of relative cell size. The aver-
age cell size increased from passage one to passage
five (no analysis for passages six and seven was done
because of the limited cell numbers available). The
peak of the forward scatter histogram shifted to the
right along the x axis from passage one to passage
four. In passage five, there were two peaks showing
the disparity between large and small keratinocytes
(Fig. 2).
Cell growth kinetics
The keratinocyte expansion of each generation in-
creased continuously from primary cell to passage
three. However, after passage three, the cell output
decreased sharply (Fig. 3) as opposed to human oral
keratinocytes which were able to be passaged up to 10
times (ref. 3 and unpublished data). The total expan-
sion ratio varied among the five different dogs from
1:2.5 to 1:8.8 PDT of P1 was 2.29 days; PDT of P2 was
2.96 days. From the data of five dogs, the average lag
time of primary keratinocytes was 2 days. From day 3
to day 8, the curve significantly correlated to the log
model. When the cells became confluent at day 8, the
saturation density was 1.57  105 cells/cm2 (Fig. 4).
In vitro culture of canine oral mucosa equivalent
Histology
After culturing canine composites submerged for 4
days, a keratinocyte monolayer was seen attached to
the AlloDerm. On day 11, after culturing at an air–
liquid interface for 7 days, the monolayer of oral ker-
atinocytes stratified to more than three cell layers
thick. The basal cell nuclei were cubic, whereas the
suprabasal cell nuclei were oval with the long axis
parallel to the surface of the AlloDerm. The superfi-
cial two to three cell layers were eosinophilic, showing
parakeratinization, with a narrow nucleus seen within
Figure 2. Flow cytometric analysis of relative cell size of canine oral keratinocytes from passage P0 to P5 (each of the five
colors represents a different generation: red  P1, black  P2, green  P3, blue  P4, purple  P5). [Color figure can be
viewed in the online issue, which is available at www.interscience.wiley.com.]
Figure 3. The harvested cell number of each passage of
canine oral keratinocytes (representative of five samples); y
axis  number of total cell output (106).
CANINE ORAL MUCOSA EQUIVALENT 147
the cells. On day 18, cultured at an air–liquid interface
for 14 days, three different cell layers were observed:
the basal cell layer was composed of compacted co-
lumnar cells, the suprabasal cell layer of oval or irreg-
ular-shaped keratinocytes with an eccentrically placed
nucleus, and the superficial cell layer, which contained
more than 20 parallel cell layers, with flat nuclei. The
18-day EVPOME was similar to native canine oral
mucosa, lacking only the deep rete pegs ridges and
pigmentation (Fig. 5).
Immunohistochemistry
In native canine oral buccal mucosa, p63 nuclear
expression was seen in the basal and suprabasal lay-
ers, at the base of the epidermal bulge into the dermis.
On day 4 equivalents, a majority of the cells within the
monolayer showed positive nuclear immunoreaction
with p63; on day 11 equivalents, the p63 immunopo-
sitive cells were located mainly in the basal and the
lowest suprabasal cell layers; and on day 18 equiva-
lents, positive cells were found in both the basal and
suprabasal cell layers. The percentage of positively
stained p63 cells was higher than seen in native canine
tissue (Fig. 6). Nuclear Ki-67 expression, overall, was
less than seen with p63. Day 4 equivalents showed few
positive cells; in day 11 and day 18 equivalents, posi-
tive cells were only observed in the basal cell layer,
this was in comparison to only several positive cells
noted in native buccal mucosa (Fig. 7). Involucrin
expression was found in the cytoplasm of the supra-
basal cell layer in native oral buccal mucosa. In day 4
equivalents, there was no expression, whereas in day
11 and day 18 equivalents, immunoreaction was seen
in the superior portions of the suprabasal cell layers
(Fig. 8; Table I).
GFP transfection and confocal microscopy
The average transduction efficiency of canine oral
keratinocyte was 26% (Fig. 9). There was no morpho-
logic change of the keratinocytes after transduction as
seen under a phase-contrast microscope. After sorting
Figure 5. Histological findings of native canine oral mu-
cosa (A) and canine ex vivo produced oral mucosa equivalent
of day 4 (B), day 11 (C), and day 18 (D) (hematoxylin and
eosin; original magnification, 200). [Color figure can be
viewed in the online issue, which is available at www.
interscience.wiley.com.]
Figure 4. Growth curve of primary canine oral keratino-
cyte (representative of five samples).
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by flow cytometry, the purity of GFP-positive cells
was more than 95%. On seeding onto the AlloDerm,
the GFP-positive keratinocytes formed stratified cell
layers similar to untransfected cells. Strong green flu-
orescence was observed on day 11 equivalents using
confocal microscopy when compared with the nega-
tive control containing nontransfected keratinocytes
(Fig. 10).
DISCUSSION
A chemically defined culture system, free of serum,
a xenogeneic feeder layer, and pituitary extract allows
a more accurate control of culture conditions in vitro,
reduced variability in qualitative and quantitative cul-
ture medium composition, elimination of potential
sources of (micro-) biological contamination, and the
advantage of down-stream processing (isolation of cell
culture products).16 In addition, reagents such as fetal
Figure 7. Immunohistochemical staining for Ki-67: (A) na-
tive oral buccal mucosa, (B) day 4 dog equivalent, (C) day 11
dog equivalent, (D) day 18 dog equivalent (original magni-
fication, 200). [Color figure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
Figure 6. Immunohistochemical staining for p63: (A) na-
tive oral buccal mucosa, (B) day 4 dog equivalent, (C) day 11
dog equivalent, (D) day 18 dog equivalent (original magni-
fication, 200). [Color figure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
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calf serum used in cell culture medium is difficult to
remove during washing and can trigger an immuno-
logic reaction in patients who receive cell infusions,
thus negating its use if human clinical trials are being
considered.17 The development of a serum-free cul-
ture medium for cells and, in particular, human kera-
tinocytes, has allowed marked advances to be made in
the area of keratinocyte biology.18
With this in mind, it is unfortunate, to date, that
there is no serum-free medium available to culture
animal (canine or porcine) keratinocytes. Crameri et
al.9 found that two commercial serum-free media,
KGM™ and KSFM™, which performed well in human
keratinocyte cultures, failed to support normal canine
oral keratinocyte growth consistently after the first
passage. The KGM™ and KSFM™ media that were
used contained a higher concentration of calcium, 0.15
mM and 0.09 mM, respectively, when compared with
0.06 mM seen in Epilife™ used in our investigation.
Studies have shown that keratinocytes grown in a
calcium concentration less than 0.07 mM proliferate
more rapidly and tend to differentiate more slowly,
stratify less, form less intercellular contacts, and form
fewer cornified envelopes.19 When the calcium con-
centration increases to higher levels, keratinocytes be-
gin to differentiate and express the appropriate mark-
ers.19 This might be the main reason why we have
been able to continuously culture our canine oral ker-
atinocytes up to seven passages in our experiments. In
Figure 8. Immunohistochemical staining for involucrin:
(A) native oral buccal mucosa, (B) day 4 dog equivalent, (C)
day 11 dog equivalent, (D) day 18 dog equivalent (original
magnification, 200). [Color figure can be viewed in the
online issue, which is available at www.interscience.wiley.
com.]
TABLE I
Comparison of Percentage of Immunopositive Cells




Mucosa Day 18 Equivalent
Basal Suprabasal Basal Suprabasal
p63    
Ki-67    
Involucrin    
Proportion of positive cells: , 50%; , 10% and
	50%; , 	10%; and , 0%.
Figure 9. Flow cytometry analysis of GFP-positive cells
after transduction of canine oral keratinocytes. Arrow (M1
cursor) indicates the borderline (range) showing positive
fluorescein isothiocyanate (FITC) fluorescence when com-
pared with negative control.
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addition, both KGM™ and KSFM™ media contain
bovine pituitary extraction supplement (BPE), which
is a crude animal product of undefined composition
that can be a potential source of contaminants. In
Epilife™ serum-free medium, the BPE is replaced by
purified serum albumin, transferrin, recombinant hu-
man Insulin-like Growth Factor (rhIGF-1), and pros-
taglandin E2 (PGE-2), thus maintaining a highly puri-
fied animal-free product system. BPE has also been
replaced in fabrication of our human EVPOMEs to
gain FDA approval in anticipation of our human clin-
ical trials.5
The culture kinetics of the canine oral keratinocytes
in our study showed that cell proliferation decreased
markedly after passage three resulting in a shorter
lifespan of canine cells when compared with human
oral keratinocytes grown in the same medium. This
would seem to imply that different growth conditions
and/or media are necessary to optimize the culturing
of canine oral keratinocytes. The amplification of the
canine oral keratinocytes within the first three pas-
sages was sufficient to allow us to harvest ample cells
for fabrication of the necessary equivalents for our in
vitro and planned in vivo studies. The average cell size
increased from passage one to passage five in associ-
ation with an increase in intracytoplasmic particles,
which correlated with the decrease in cell replication
and increase in cell senescence. In contrast to passage
one to passage four cells, the forward scatter of pas-
sage five cells showed two-peak patterns. In this
study, smaller cells appeared among larger cell colo-
nies in passage five and passage six culture cells. The
second growth surge, observed in later passages in
extended culture periods, has previously been ob-
served by Lauer et al.20 It appears that cells of a
smaller size may have a critical role in the proliferative
potential of keratinocytes seen in later culture periods
as this is consistent with the physical stature of stem
cells.21
Investigations have shown that keratinocytes grown
in serum-free medium behave differently than kera-
tinocytes grown in medium containing serum.22 Sev-
eral studies have suggested that the serum-free me-
dium encourages keratinocytes to change to a
proliferative phenotype.15,23 Unfortunately, the se-
rum-containing medium used in these studies was not
depleted of calcium, and the actual concentration
present was not known. This makes it difficult to
determine the effects of the calcium concentration ver-
sus the presence or absence of serum to explain the
difference in proliferation and differentiation effects
on keratinocyte in these varied media. Our data
showed that Epilife™ serum-free medium supported
rapid keratinocytes amplification at the earlier stages
in our culture system, but was not as long-lived as
chelexed serum-contained medium, devoid of cal-
cium, in the later phases (data not shown). The study
by Altankov et al.22 revealed that the human keratin-
ocytes cultured in a serum-free medium had an ad-
herent phenotype based on integrin 
1 expression but
when human keratinocytes were cultured in a serum-
contained medium the cells changed to a migratory
phenotype. In addition, keratinocytes that grew well
in a serum-free medium failed to reorganize fibronec-
tin as a matrix substrate which binds to integrin 
1.22
A reversible phenotypic alteration of keratinocytes in
vitro, such as adherent, proliferative, or motile, may
depend on adherent inhibition factors contained in
serum. According to Marcelo et al.,24 the normaliza-
tion of the fatty acids composition of the cell mem-
brane gave rise to a slower growth rate, a decreased
passage potential, and a more differentiated cell mor-
phology in serum-free condition. Because a 10–20%
serum-supplemented medium does not affect cul-
tured keratinocytes to normalize fatty acid composi-
tion of cell membrane, essential fatty acids deficiency
in a serum-free culture system appears to outperform
a serum-contained medium to expand a canine kera-
tinocyte population rapidly and to be able to obtain a
Figure 10. Laser confocal microscopy: (A) strong green
fluorescence in EVPOMEs fabricated with GFP-transduced
dog oral keratinocytes, (B) minimal green autofluorescence
in EVPOMEs fabricated with nontransduced dog oral kera-
tinocytes (original magnification, 100). White broken line
shows an interface between epithelial layer (EP) and dermal
component, AlloDerm (DE).
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sufficient number of keratinocytes in a shorter period
of time.
Oral mucosa is classified into two basic types (ex-
cluding the specialized mucosa of the tongue) accord-
ing to the pattern of keratinization: keratinized or
masticatory mucosa—which includes the palate and
attached mucosa and nonkeratinized mucosa which
includes the buccal and floor of the mouth mucosa.25
In our investigation, we choose to use keratinocytes
from buccal mucosa for several reasons: first, it is
plentiful because both cheeks and vestibules can be a
source of tissue; secondly, this donor site was rela-
tively easy to close because of the laxity of mucosa in
this area; and finally, the palate is to be the recipient
site for our in vivo grafting of the canine EVPOME and
thus needed to remain unscathed. Our histological
results demonstrated that the keratinization pattern of
the canine equivalent was consistent with the original
oral buccal mucosa only lacking in the deep ridges
and pigmentation seen in native canine oral mucosa.
The immunohistochemical staining showed that the
day 18 equivalent had a similar p63, Ki-67, and involu-
crin expression pattern, as native canine buccal mu-
cosa that substantiate the efficacy of the use of the
canine EVPOME in our studies.
p63 transcription factor, a p53 homolog, has been
identified as an essential factor for regenerative pro-
liferation in epithelial development. p63/ mice have
major defects in their limb and craniofacial develop-
ment, as well as a striking absence of stratified epithe-
lia.26 Pellegrini et al. found that p63 is abundantly
expressed by epidermal and limbal holoclones, but is
undetectable in paraclones.27 Transit amplifying ker-
atinocytes have a reduction in p63 expression imme-
diately after they leave the stem cell compartment
implying p63 may be a keratinocyte stem cell
marker.27 Immunohistochemical stain of p63 in hu-
man epithelial tissues shows that p63 staining is local-
ized to the basal cells of various epithelia.26 In our
experiment, p63-positive nuclei were found in the
basal cells in native canine oral buccal mucosa, espe-
cially between the dermal ridges. The same staining
pattern was shown in our canine EVPOMEs. Ki-67, a
cell proliferation-associated human nuclear antigen, is
expressed throughout the cell cycle, reaching maxi-
mum at G2/M. Ki-67 expression is of value in detect-
ing dividing keratinocytes in the human epidermis.28
Although the Ki-67 expression in native canine oral
buccal mucosa, as well as equivalents, was mainly
found in the basal cells layers, the percent positive
cells was much lower than seen with p63. This implies
that most p63-positive cells are in a quiescent phase
(G0) of cell cycle instead of a proliferating phase (S/G2/
M), which is a known characteristic of stem cells.29,30
Investigators have performed human clinical trials
without being able to definitively determine if the
keratinocytes present at the grafted site are trans-
planted or resident keratinocytes migrating in from
the periphery of the wound.2,31 This is a critical point
to assess because if the transplanted keratinocytes on
the EVPOME do not survive the grafting procedure, it
calls into question the efficacy of using them as a
source of gene products once they are transfected.
Therefore, in this investigation, we attempted to label
keratinocytes, on the soon-to-be-grafted canine
EVPOME, by transducing them with a reporter gene,
GFP, using a lentiviral vector, in order to track the oral
keratinocytes on grafted EVPOMEs. Lentivirus vec-
tors are a family of retroviral vectors, that have several
advantages in cellular transduction: they complement
the features of efficient integration in the chromatin,
there is an absence of viral genes from the genetic
information transferred to the recipient, there is a lack
of preexisting immunity in the recipient, and, even
more important, they are able to infect nondividing
cells.32 By injecting a lentiviral vector into human skin
tissue, it will successfully target all major cell types
within the human skin including keratinocytes. In
addition, studies using lentiviral vectors encoding for
human erythropoietin, transfected into transplanted
cells, were able to produce a dose-dependent increase
in serum human erythropoietin level.33 This is impor-
tant because we have future studies planned to trans-
fect our oral keratinocytes with a functional gene in
place of GFP. Although the lentiviral vector was de-
rived from human immunodeficiency virus-1, it has
become an invaluable gene transfer tool by showing
its efficacy and biosafety by changing it to a nonpri-
mate immunodeficiency virus vector.32 The feline im-
munodeficiency virus vector (FIV) we used in our
experiment showed a maximum of 30% transduction
efficiency and a long-term expression of GFP within
our canine equivalent. Also of importance, the trans-
ducted oral keratinocytes still possessed the ability to
form stratified cell layers once seeded on the Allo-
Derm, which suggested that their normal function
was not influenced by the incorporated viral gene. By
using GFP-transducted EVPOME, in vivo, the source
of keratinocytes that covers the wound, at last, can be
assessed. In addition, the feature of infecting nondi-
viding cells by the lentiviral vector is an advantage
over other retroviral vectors because one can now
target the slowly dividing stem cell.34–36
In conclusion, canine EVPOMEs were successfully
fabricated in an identical manner to our human
EVPOMEs. The canine EVPOMEs were similar in na-
ture to native canine oral buccal mucosa. GFP-trans-
fected canine oral keratinocytes used to fabricate ca-
nine EVPOMEs could be identified within the canine
EVPOME. In vivo studies utilizing the GFP-transfected
canine EVPOMEs are presently underway.
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